Proxy advisory SES has raised red flag in governance and disclosure at listed hospital firm Healthcare Global Enterprises (HCG) and the amalgamation of its wholly-owned subsidiary HCG Pinnacle Oncology Pvt Ltd.
Stakeholders Empowerment Services (SES) has asked minority shareholders of HCG to vote against the resolution as the company has made inadequate disclosures regarding the amalgamation. It did not, however, question the justification for the proposed merger.
SES said the cancer hospital operator has been “economical with the truth.”
“Earlier, the (target) company had only been a 51 per cent subsidiary and if the merger was to happen it would have to go through the Tribunal route. Therefore, SES is of the opinion that to avoid the Tribunal route, HCG has carried out the transaction in two steps (by first buying up the remaining stake and then effecting an amalgamation.),” SES added.
When contacted, a spokesperson for HCG told BusinessLine : “HCG Pinnacle Oncology Pvt Ltd is a 100 per cent wholly-owned subsidiary of the company (HCG) and the amalgamation is well in compliance with all stated rules, regulations and also meets all governance standards.”
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.